Peer-reviewed research — Ophthalytics DR detection, validated on real-world fundus images Read the study

Our Solutions

Four Retinal AI Solutions.
One Foundational Platform.

Ophthalytics builds AI that turns a retinal image into actionable diagnostic intelligence—purpose-built for every point in the care continuum, from primary care screening to clinical research.

Ocula360 Multimodal AI Retinal Platform dashboard with 7-field overlay
Flagship

Ocula360

Foundational Retinal AI

Our flagship AI engine, built on a foundational model architecture to detect multiple retinal diseases from a single image. Ocula360 powers scalable screening, advanced DRSS scoring, and future-ready multimodal applications across clinical care and research.

  • Multi-Disease Detection
  • DRSS Scoring
  • Explainable & Multimodal
Learn more about Ocula360

Built on Ocula360

One foundation. Four purpose-built deployments.

4+

Diseases detected

250K+

Patients screened

<2s

Per-image inference

The Platform

One Platform. Four Deployments.

Ocula360 is the foundation. Nsight360, 2nd Opinion, and Ophthal360 are purpose-built deployments of that foundation — each tuned for the workflows, decision points, and volume of a specific care setting.

Find the right solution for your organization.

Whether you're screening at the point of care, supporting diagnosis, or running a clinical trial, we'll help you identify which solution fits your workflow.